Malaysian Genomics seeks growth in cell therapy, genetic screening


KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd is optimistic that its efforts in cell therapy, genetic screening and clinical trials are foundational for its future growth and sustainability.

"In fact, prospects for Malaysian Genomics remain robust. The group is well-positioned as a leading provider of genetic screening, genome analysis, and biopharmaceutical products and services in Southeast Asia.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Light at the end of the tunnel
Understanding the warrant of distress
Are convention halls still good investments?
Ringgit likely to trade cautiously between RM4.09 and RM4.11 vs US dollar next week
Strong momentum seen for Vietnam equities
Asset managers in risk-on mode
Rising DRAM prices may hit consumers
Asia-Pacific ratings hold firm
HK’s lure for key IPO investors
Fewer stocks spur IPO hunt

Others Also Read